Navigation Links
NxStage Reports First Quarter 2013 Financial Results
Date:5/2/2013

olidated Statements of Comprehensive Loss
(in thousands, except per share data)
(unaudited)Three Months Ended
March 31,  20132012Revenues

$
,644$
56,951Cost of revenues

37,64435,639Gross profit

24,00021,312Operating expenses:Selling and marketing

10,6969,920Research and development

5,1083,897Distribution

4,9084,532General and administrative

7,8246,622Total operating expenses

28,53624,971Loss from operations

(4,536)(3,659)Other expense:Interest expense

(150)(1,193)Other expense, net

(176)(52)(326)(1,245)Net loss before income taxes

(4,862)(4,904)Provision for income taxes

132240Net loss

$   (4,994)$
(5,144)Net loss per share, basic and diluted

$
(0.08)$
(0.09)Weighted-average shares outstanding, basic and diluted

59,38155,773Other comprehensive gain

145173Total comprehensive loss

$   (4,849)$
(4,971) NxStage Medical, Inc.Condensed Consolidated Balance Sheets(in thousands, except share data)(unaudited)March 31,December 31,20132012ASSETSCurrent assets:Cash and cash equivalents

$

99,803$

106,439Accounts receivable, net

22,05818,990Inventory

36,96633,504Prepaid expenses and other current assets

4,8252,534Total current assets

163,652161,467Property and equipment, net

37,31736,320Field equipment, net

10,29710,101Deferred cost of revenues

36,13538,028Intangible assets, net

19,12019,819Goodwill

42,42142,421Other assets

3,2613,793Total assets

$

312,203$

311,949LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

$

20,593$

16,645Accrued expenses

19,56120,400Other current liabilities

2,1652,187Total current liabilities

42,31939,232Deferred revenues

'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
2. NxStage Names Robert G. Funari Chairman Of The Board
3. NxStage Completes Move to Direct Sales In UK
4. NxStage Educational Reception at Annual Dialysis Conference Features Celebrity and Former NxStage User Stephen Furst
5. NxStage Reports Record Fourth Quarter and Full-Year 2012 Financial Results
6. NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients
7. NxStage Announces CE Mark Approval for New High Flow Capabilities with System One
8. NxStage Announces CE Mark Approval for Nocturnal Home Hemodialysis
9. NxStage Initiates 2013 Call to Action Campaign with Launch of Hemodialysis At Home: A Better Way For a Better Life
10. NxStage Home Hemodialysis Patient Awareness Tour Kicks Off January 29th
11. Robert Funari Joins NxStage Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014  Casen Buswell has a ... muscles to harden.  His case is one of only 14 ... world.  The only hospital in the United States ... world, offering treatment with the dual wave-length laser, is Methodist ... San Antonio . Using a laser available in ...
(Date:9/18/2014)... Sept. 18, 2014  Decision Resources Group finds ... the United States , 54 percent of ... inhibitor Tafinlar for BRAF -mutation-positive unresectable or ... prescribed GlaxoSmithKline,s MEK inhibitor Mekinist. Among current non-prescribers ... percent and 43 percent, respectively) expects to prescribe ...
(Date:9/18/2014)... PLYMOUTH MEETING, Pa. , Sept. 18, 2014 /PRNewswire/ ... of innovative approaches to diagnosing and treating Autism Spectrum ... an Exclusive License Agreement with The Research Foundation for ... this Agreement, Iliad will provide a new biomarker to ... associated with susceptibility to ASD. This biomarker is expected ...
Breaking Medicine Technology:Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 3
... , COLLEGE STATION, ... , MD, FACS, of The Texas Institute for Thyroid and Parathyroid ... College Station Medical Center in College Station, Texas . ... in North America to be recognized by Intuitive Surgical ...
... , Jan. 14 In the keynote address at ... Lechleiter , Ph.D., chairman and CEO of Eli Lilly and Company, ... edge in innovation and improving our focus on medical innovation,s richest ... in the coming decade.  His speech focused on bioscience innovation, a ...
Cached Medicine Technology:Milestone Achieved in Revolutionary Robotic Thyroid Surgery 2Lilly CEO Stresses Human Element in Driving Medical Innovation 2Lilly CEO Stresses Human Element in Driving Medical Innovation 3
(Date:9/18/2014)... A unique partnership to support private efforts to provide ... provide a model for similar efforts should federal officials ... of reform of the VA health system, according to ... Veterans Initiative, a joint project of philanthropic groups and ... patient care, education and other services to veterans and ...
(Date:9/18/2014)... NY (PRWEB) September 18, 2014 ItsHot.com, ... NY, is now offering a 65-80% discount on its ... a whopping 71% off on its 14K Gold Pave ... diamond band can now be bought for just $775. ... 406147. , Talking about this diamond band, a representative ...
(Date:9/18/2014)... Pathways Home Health & Hospice has ... Medical Director. Prior to accepting the directorship, Brown ... Pathways KIDS, adult palliative care, and hospice teams that ... Counties. , In her new position, Brown is ... program. She will supervise five medical directors who are ...
(Date:9/18/2014)... HealthDay Reporter THURSDAY, Sept. ... that testosterone replacement therapy effectively treats normally sagging levels of ... Drug Administration advisory panel said Wednesday. The panel, from ... of the popular drugs and require drug makers to conduct ... according to Bloomberg News . "The whole idea ...
(Date:9/18/2014)... (Sept. 17, 2014) -- Two independent groups of ... the University of Kentucky, and Charles Lowenstein, MD, ... studies exploring the role that a gene called ... , According to Whiteheart, previous genome-wide association studies ... factor that regulates a protein called Von Willebrand ...
Breaking Medicine News(10 mins):Health News:Study provides insight about providing private mental health service to veterans 2Health News:Study provides insight about providing private mental health service to veterans 3Health News:ItsHot.com Now Offering 65-80% Discount on its Striking Collection of Diamond Wedding Bands 2Health News:Dr. Ellen Brown Promoted to Chief Medical Director at Pathways Home Health & Hospice 2Health News:FDA Panel: Limit Testosterone Drug Use 2Health News:FDA Panel: Limit Testosterone Drug Use 3Health News:FDA Panel: Limit Testosterone Drug Use 4Health News:University of Kentucky research explores STXBP5 gene and its role in blood clotting 2
... gap is alive and well in heart disease, a new international ... to treatment in both heart attack and severe chest pain. ... twice as likely as men to have normal or mild results ... blockage taking up more than 50 percent of any one blood ...
... ... Flows Increase, BIRMINGHAM, Ala., May 6 HealthSouth,Corporation (NYSE: ... first quarter ended March 31, 2008. Compared to the,first quarter of ... net income increased by $76.4 million., "The results of the ...
... and,Mississippi still working to recover from the Hurricane Katrina ... Department of,Health and Human Services (HHS)., "HHS continues ... health care,problems created by Hurricane Katrina," Secretary Mike Leavitt ... make sure the citizens of these,states have continued access ...
... Today at 5:30 p.m. EDT, FRAZER, Pa., ... that a Joint Advisory Committee to the U.S. ... approval of an expanded,label for FENTORA(R) (fentanyl buccal ... opioid-tolerant patients with chronic pain conditions.,The panel expressed ...
... have shown for the first time that thrombopoietin (TPO), ... to increase platelet count in cancer patients during chemotherapy, ... heart attack. , The study, led by ... the division of cardiothoracic surgery, was published in the ...
... now register to attend TCT2008 (Transcatheter Cardiovascular Therapeutics), ... Foundation. TCT gathers leading medical researchers and clinicians ... developments in the field of interventional cardiology and ... state-of-the-art techniques and training to interventional cardiologists around ...
Cached Medicine News:Health News:Women and heart attack: Study finds failure to recognize symptoms, failure to treat appropriately 2Health News:Women and heart attack: Study finds failure to recognize symptoms, failure to treat appropriately 3Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 2Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 3Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 4Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 5Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 6Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 7Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 8Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 9Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 10Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 11Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 12Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 13Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 14Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 15Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 16Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 17Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 18Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 19Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 20Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 21Health News:Hospitals in Louisiana and Mississippi to Receive More Katrina Recovery Grants 2Health News:Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA 2Health News:Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA 3Health News:Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA 4Health News:Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA 5Health News:Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA 6Health News:Naturally-occuring protein may be effective in limiting heart attack injury and restoring function 2Health News:Media registration now open for TCT2008 2
Inquire...
... Novas Point-of-Care Manager is ... gas and critical care ... the industry. PDM ... workstation designed to effortlessly ...
... The ISI Micro Nest is the wall-mounted organizer ... a variety of sizes and diameters. The Micro ... the right brush for the cleaning task. These ... specifically for those hard-to-clean instruments such as cannulas. ...
... is the non-silicone lubricant designed to "spot" ... lubricates sticky pivot points, hinges, box joints ... allows you to lubricate with precision. Safe ... Ideal for carts, hinges, medical equipment, and ...
Medicine Products: